
Stanford
http://www.stanfordgroup.com/#Stanford provides institutional investment services and private wealth management services. The firm also offers equity research to its clients in the consumer, media, energy, financial, healthcare, technology and water/environment sectors.
View Older Stories
-
atai Life Sciences (ATAI) Appoints Stephen Bardin as CFO
-
Quantum-Si incorporated (QSI) Appoints Vikram Bajaj, Ph.D., to Board of Directors
-
biote (BTMD) Appoints Ross W. McQuivey as Chief Medical Officer
-
Xilio Therapeutics (XLO) Announces Promotion of Martin Huber, M.D., to President
-
KKR & Co. (KKR) Appoints Raymond J. McGuire as New Independent Director
-
Lantheus Holdings (LNTH) Announces Promotion of Paul Blanchfield to Chief Operating Officer
-
Creative Medical Technology (CELZ) Enters Agreement with Greenstone Biosciences for Development of a Next Generation iPSC Pipeline for its ImmCelz Immunotherapy Platform
-
180 Life Sciences Corp (ATNF) Provides Update on Correspondence Received from U.K. and U.S. Regulatory Authorities on Pathway for a Therapy That Could Prevent Progression of Early-Stage Dupuytren’s
-
Premier Medical Laboratory Services Now Offering AditxtScore Personalized Immune Test for COVID-19(ADTX)
-
Sierra Metals (SMTS) Announces Appointment of New Chair & Addition to the Board
-
Ichor (ICHR) Announces Jorge Titinger Joins Board of Directors
-
Eiger BioPharmaceuticals (EIGR) Announces New Data Supporting Broader Potential of Avexitide in Patients with Post-Bariatric Hypoglycemia and Hyperinsulinemic Hypoglycemia After Gastrointestinal Surge
-
SI-BONE Inc. (SIBN) Announces FDA Clearance for Expanded Indication of the iFuse-TORQ® Implant System
-
Forte Biosciences (FBRX) Announces the Appointment of Dr. Hubert Chen, MD as Chief Scientific Officer and President
-
Alpine Immune Sciences (ALPN) Appoints Andrew S. Sandler as Chief Medical Officer
-
Inozyme Pharma Inc. (INZY) Appoints Kurt Gunter, M.D., as Chief Medical Officer
-
Viracta Therapeutics (VIRX) Approved to Advance to Higher Dosing in Phase 1b/2 Trial of Nana-val
-
Adamis Pharmaceuticals (ADMP) Provides Update on Clinical Study Assessing Tempol for the Treatment of COVID-19
-
Alpine Immune Sciences (ALPN) Provides Update on ALPN-303
-
Rezolute Inc. (RZLT) Appoints Brian Roberts as Chief Medical Officer
-
Beyond Air's (XAIR) Beyond Cancer Appoints Jedidiah Monson as Chief Medical Officer
-
BeyondSpring (BYSI) Presents New Clinical Data in the Chemotherapy-Induced Neutropenia
-
Navitas Semiconductor Corporation (NVTS) Appoints Ron Shelton as CFO
-
DuPont (DD) Announces Election of Kristina M. Johnson to Board of Directors
-
CuriosityStream (CURI) Appoints Peter Westley as CFO
-
Radius Health (RDUS) Appoints Jennifer A. Jarrett and Susan Vissers Lisa to its Board
-
Poseida Therapeutics (PSTX) Appoints Charles M. Baum to its Board
-
MiMedx Group (MDXG) Issues Letter to Shareholders
-
Broadway Financial (BYFC) Appoints John Driver to its Board
-
Snackhealthy, Inc. (SNAX) Appoints Christopher Boever as New CEO
-
Lee Enterprises (LEE) Elects Dr. Shaun McAlmont to Board of Directors
-
Insulet (PODD) Announces CEO Transition
-
Smart for Life (SMFL) Appoints Darren C. Minton as CEO
-
Esports Entertainment Group (GMBL) Appoints Jan Jones Blackhurst to its Board
-
CSS Entertainment's (CSSE) Cracke Announces New Originals, Exclusives, Movies, and Series for May
-
E2open (ETWO) Names Marje Armstrong as New Chief Financial Officer
-
Jasper Therapeutics (JSPR) Reports Updated Data from Phase 1 Clinical Trial of JSP191
-
Pixelworks (PXLW) Appoints Dean Butler to its Board
-
eBay (EBAY) Names Eddie Garcia Chief Product Officer
-
Cadre Holdings (CDRE) Appoints Deborah DeCotis to its Board
-
Smith Micro Software (SMSI) Appoints New Members to the Board of Directors
-
Cytokinetics (CYTK) Announces Changes to Board of Directors
-
FSD Pharma Inc. (HUGE) Issues Corporate Updates
-
Natera (NTRA) Announces Appointments to Organ Health Medical Affairs Leadership Team
-
Cepton, Inc. (CPTN) Announces Chief Financial Officer Transition
-
Hasbro (HAS) Announces Elizabeth Hamren and Blake Jorgensen Join Board of Directors
-
Alpine Immune Sciences (ALPN) Reports Key Preclinical Rationale for Davoceticept (ALPN-202)
-
Legend Biotech (LEGN) Announces Appointment of Global Head of Research and Early Development
-
Nuvalent (NUVL) Appoints Anna Protopapas as Chair of Board of Directors
-
Krystal Biotech (KRYS) Reports Publication of Phase 1 and 2 Clinical Trial of Beremagene Geperpavec